If the patient has no genetic abnormalities in the complement pathway, no identifiable causes of secondary HUS, and normal ADAMTS13 activity, then the TMA is idiopathic HUS.8 The gene discussed is ADAMTS13; the disease is hemolytic-uremic syndrome.